Skip to content

Clinical trials

Leukemia, B-Cell trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, B-Cell Country / region: Poland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20121
20141
20161
20171
20192
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Acerta Pharma BV1
Affimed GmbH1
AstraZeneca1
Institut de Recherches Internationales Servier1
Loxo Oncology, Inc.1
Merck Sharp & Dohme LLC1
Pharmacyclics Switzerland GmbH1
Polish Lymphoma Research Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, B-Cell12
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, B-Cell3
Lymphoma, Non-Hodgkin3
Neoplasms3
Leukemia, Lymphoid2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Recurrence2
Bronchiolitis Obliterans Syndrome1
Graft vs Host Disease1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.